Edgewell Personal Care Company (EPC)

Sage Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Sage Therapeutics stock have a consensus rating of "Buy" and an average price target of $29.29, which forecasts a 32.96% increase in the stock price over the next year. The lowest target is $21 and the highest is $40.

Price Target: $29.29 (+32.96%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$21	$29.29	$32	$40
Change	-4.68%	+32.96%	+45.26%	+81.57%

Analyst Ratings

The average analyst rating for Sage Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	2	2	2
Hold	2	2	2	2	2	3
Sell	1	1	1	1	1	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Susan Anderson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $35 → $32	Strong Buy	Maintains	$35 → $32	+45.26%	Aug 6, 2025
Peter Grom UBS	UBS	Hold Maintains $28 → $21	Hold	Maintains	$28 → $21	-4.68%	Aug 6, 2025
Lauren Lieberman Barclays	Barclays	Hold Maintains $26 → $22	Hold	Maintains	$26 → $22	-0.14%	Aug 6, 2025
Dara Mohsenian Morgan Stanley	Morgan Stanley	Sell → Hold Upgrades $26 → $23	Sell → Hold	Upgrades	$26 → $23	+4.40%	Aug 6, 2025
Lauren Lieberman Barclays	Barclays	Hold Maintains $25 → $26	Hold	Maintains	$25 → $26	+18.02%	Jul 15, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.27B

Increased by 0.77%

from 2.25B

Revenue Next Year

2.33B

Increased by 2.47%

from 2.27B

EPS This Year

2.95

Increased by 49.96%

from 1.97

EPS Next Year

3.09

Increased by 4.66%

from 2.95

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Sep 30, 2020	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026	Sep 30, 2027
Revenue	1.95B	2.09B	2.17B	2.25B	2.25B	2.27B	2.33B	2.38B
Revenue Growth	-8.94%	7.06%	4.04%	3.68%	0.09%	0.77%	2.47%	2.28%
EPS	1.24	2.13	1.85	2.21	1.97	2.95	3.09	3.41
EPS Growth	-	71.77%	-13.15%	19.46%	-10.86%	49.96%	4.66%	10.35%
Forward PE	-	-	-	-	-	7.46	7.13	6.46
No. Analysts	-	-	-	-	-	9	9	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	2.4B	2.4B	2.5B
Avg	2.3B	2.3B	2.4B
Low	2.2B	2.2B	2.3B

Revenue Growth

Revenue Growth	2025	2026	2027
High	5.1%	7.4%	7.0%
Avg	0.8%	2.5%	2.3%
Low	-2.9%	-1.4%	-1.8%

EPS Forecast

EPS	2025	2026	2027
High	3.15	3.28	3.82
Avg	2.95	3.09	3.41
Low	2.81	2.89	3.19

EPS Growth

EPS Growth	2025	2026	2027
High	59.9%	10.9%	23.6%
Avg	50.0%	4.7%	10.3%
Low	42.8%	-2.1%	3.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.